Tyler S Bartholomew
Datos Biográficos
| ID | 6067413 |
|---|---|
| NOMBRE | Tyler S Bartholomew |
| NOMBRES | Tyler S |
| APELLIDO | Bartholomew |
| FIRMA | BARTHOLOMEW T S |
| AFILIACIONES | University of Miami |
| ORCID | 0000-0002-9384-0812 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 17 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 17 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2019 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Intravenous Methamphetamine Use, HIV Status and PrEP Uptake Among a U.S. Sample of 29,880 Gender and Sexual Minorities, 2022–2023
Barriers, beliefs, and biomedical prevention
BACKGROUND: Peripregnant women who use drugs and are involved in the criminal legal system (CLS) face elevated risks of human immunodeficiency virus (HIV) acquisition due to overlapping vulnerabilities, including sexual violence, structural instability, and limited access to preventive healthcare. The unique needs of this population are routinely overlooked in both clinical practice and research. This qualitative study explores peripregnant women…
Promises and pitfalls of safer smoking supply distribution in the United States
With rising prevalence of smoking unregulated drugs across the United States, there is a need for more community-based distribution of safer smoking supplies (e.g., glass pipes) to reduce health harms for people who smoke drugs. While smoking supplies are increasingly offered through harm reduction organizations (HROs), which have predominantly focused on addressing injection-related harms, little is known about HROs’ experiences implementing thi…
Long-Acting Injectable Prep for People Who Inject Drugs at a Syringe Services Program
Although people who inject drugs (PWID) are at high risk of acquiring HIV, knowledge and uptake of pre-exposure prophylaxis (PrEP) for HIV prevention among this population remain low due to numerous psychosocial and structural barriers. Multiple implementation strategies have been proposed to address this gap, notably providing long-acting injectable (LAI) formulations of PrEP and offering PrEP at syringe services programs (SSPs). This qualitativ…
The Simplest Way to Go”
Long-acting injectable PrEP was approved for use in the US in 2021 but roll out has been slow, with few studies exploring uptake among cisgender women who inject drugs (WWID). We purposively recruited 25 WWID within 30-days of receiving a PrEP prescription from a low-barrier clinic co-located with a syringe services program to complete semi-structured interviews about PrEP product choice. We used an intersectional lens to compare decision-making …
Blending de-implementation and implementation to promote adoption of universal PrEP guidelines
In 2021, the Centers for Disease Control and Prevention (CDC) proposed updated clinical practice guidelines for Pre-Exposure Prophylaxis (PrEP), marking a significant shift from risk-based screening to discussing PrEP with all sexually active adults. To ensure widespread adoption of new guidelines, this commentary posits that intentional de-implementation of the previous CDC guidelines is necessary to facilitate the adoption, implementation, and …
Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019–2020
Both governmental investment in harm reduction programming and needs-based distribution of syringes increased service uptake and thus should be expanded and sustained to reduce harms associated with injection drug use
Injection and Sexual Behavior Profiles among People Who Inject Drugs in Miami, Florida
BACKGROUND: The dynamics of injection drug use and higher-risk sexual practices compound the risk of HIV and HCV acquisition. Published literature on people who inject drugs (PWID) has examined risk of infection assuming homogeneity of cohort behavior. Categorizing subgroups by injection and sexual risk can inform a more equitable approach to how syringe services programs (SSPs) adapt harm reduction resources and implementation of evidence-based …
A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the Covid-19 pandemic
This measurement framework is intended to increase the quality and timeliness of research on the impacts of COVID-19 in the context of the current pandemic and future crises. Next steps include a ranking process to narrow the drivers of change in health risks to a concise set of indicators that adequately represent framework components, can be written as measurable indicators, and are quantifiable using existing data sources, as well as a publicl…
The University of Miami Infectious Disease Elimination Act Syringe Services Program
After the closure of pill mills and implementation of Florida’s Prescription Drug Monitoring Program in 2010, high demand for opioids was met with counterfeit pills, heroin, and fentanyl. In response, medical students at the University of Miami Miller School of Medicine embarked on a journey to bring syringe services programs (SSPs) to Florida through an innovative grassroots approach. Working with the Florida Medical Association, students learne…
Impact of Behavioral Health Consultation on Hepatitis C Treatment Outcomes at a Federally Qualified Health Center; Philadelphia, PA
Influences of immigration stress and occupational exploitation on Latina seasonal workers’ substance use networks
US female Latina seasonal farm workers (LSW) are a medically underserved community experiencing severe health disparities. We explored the relationship between alcohol and prescription medication, and LSW social networks using a qualitative approach. In 2015, this study used convenience sampling to recruit 28 LSWs in South Florida for three focus group discussions in Spanish. Focus groups were translated to English for analysis, which employed a …
Syringe services program (SSP) operational changes during the Covid-19 global outbreak
Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program
Bundled opt-out HIV/HCV testing substantially increased the percentage of SSP clients who received HIV and HCV rapid tests at enrollment into the program, and the effect remained stable across the 22 months post opt-out testing policy. Future investigation must assess PWID-level perspective of testing preferences and examine whether this testing approach improves HIV/HCV detection among PWID previously unaware of their status
Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program
Existing interventions among this population to mitigate infectious disease risk, such as SSPs, can be a used to engage differing PWID populations. However, multi-component, targeted preventive interventions and need-based syringe distribution policies are required to further reduce HIV and HCV risk among various PWID populations
Student-Run Free Clinic at a Syringe Services Program, Miami, Florida, 2017–2019
Student-Run Free Clinic at a Syringe Services Program, Miami, Florida, 2017–2019 Margaret E. C. Ginoza BA, Jasmine Tomita-Barber MSc, Jason Onugha MS, Corinne Bullock MS, Tyler S. Bartholomew BS, Hansel E. Tookes MD, MPH, and David P. Serota MD, MSc Affiliation Margaret E. C. Ginoza, Jasmine Tomita-Barber, Jason Onugha, and Corinne Bullock are with the Department of Medical Education, University of Miami Miller School of Medicine, Miami, FL. Tyle…
Rapid Identification and Investigation of an HIV Risk Network Among People Who Inject Drugs –Miami, FL, 2018
Prevention of HIV outbreaks among people who inject drugs remains a challenge to ending the HIV epidemic in the United States. The first legal syringe services program (SSP) in Florida implemented routine screening in 2018 leading to the identification of ten anonymous HIV seroconversions. The SSP collaborated with the Department of Health to conduct an epidemiologic investigation. All seven acute HIV seroconversions were linked to care (86% with…
Sin obras prominentes en esta página.
Rapid Identification and Investigation of an HIV Risk Network Among People Who Inject Drugs –Miami, FL, 2018
Prevention of HIV outbreaks among people who inject drugs remains a challenge to ending the HIV epidemic in the United States. The first legal syringe services program (SSP) in Florida implemented routine screening in 2018 leading to the identification of ten anonymous HIV seroconversions. The SSP collaborated with the Department of Health to conduct an epidemiologic investigation. All seven acute HIV seroconversions were linked to care (86% with…
Influences of immigration stress and occupational exploitation on Latina seasonal workers’ substance use networks
US female Latina seasonal farm workers (LSW) are a medically underserved community experiencing severe health disparities. We explored the relationship between alcohol and prescription medication, and LSW social networks using a qualitative approach. In 2015, this study used convenience sampling to recruit 28 LSWs in South Florida for three focus group discussions in Spanish. Focus groups were translated to English for analysis, which employed a …
Syringe services program (SSP) operational changes during the Covid-19 global outbreak
Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program
Bundled opt-out HIV/HCV testing substantially increased the percentage of SSP clients who received HIV and HCV rapid tests at enrollment into the program, and the effect remained stable across the 22 months post opt-out testing policy. Future investigation must assess PWID-level perspective of testing preferences and examine whether this testing approach improves HIV/HCV detection among PWID previously unaware of their status
Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program
Existing interventions among this population to mitigate infectious disease risk, such as SSPs, can be a used to engage differing PWID populations. However, multi-component, targeted preventive interventions and need-based syringe distribution policies are required to further reduce HIV and HCV risk among various PWID populations
Student-Run Free Clinic at a Syringe Services Program, Miami, Florida, 2017–2019
Student-Run Free Clinic at a Syringe Services Program, Miami, Florida, 2017–2019 Margaret E. C. Ginoza BA, Jasmine Tomita-Barber MSc, Jason Onugha MS, Corinne Bullock MS, Tyler S. Bartholomew BS, Hansel E. Tookes MD, MPH, and David P. Serota MD, MSc Affiliation Margaret E. C. Ginoza, Jasmine Tomita-Barber, Jason Onugha, and Corinne Bullock are with the Department of Medical Education, University of Miami Miller School of Medicine, Miami, FL. Tyle…
The University of Miami Infectious Disease Elimination Act Syringe Services Program
After the closure of pill mills and implementation of Florida’s Prescription Drug Monitoring Program in 2010, high demand for opioids was met with counterfeit pills, heroin, and fentanyl. In response, medical students at the University of Miami Miller School of Medicine embarked on a journey to bring syringe services programs (SSPs) to Florida through an innovative grassroots approach. Working with the Florida Medical Association, students learne…
Impact of Behavioral Health Consultation on Hepatitis C Treatment Outcomes at a Federally Qualified Health Center; Philadelphia, PA
Injection and Sexual Behavior Profiles among People Who Inject Drugs in Miami, Florida
BACKGROUND: The dynamics of injection drug use and higher-risk sexual practices compound the risk of HIV and HCV acquisition. Published literature on people who inject drugs (PWID) has examined risk of infection assuming homogeneity of cohort behavior. Categorizing subgroups by injection and sexual risk can inform a more equitable approach to how syringe services programs (SSPs) adapt harm reduction resources and implementation of evidence-based …
A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the Covid-19 pandemic
This measurement framework is intended to increase the quality and timeliness of research on the impacts of COVID-19 in the context of the current pandemic and future crises. Next steps include a ranking process to narrow the drivers of change in health risks to a concise set of indicators that adequately represent framework components, can be written as measurable indicators, and are quantifiable using existing data sources, as well as a publicl…
Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019–2020
Both governmental investment in harm reduction programming and needs-based distribution of syringes increased service uptake and thus should be expanded and sustained to reduce harms associated with injection drug use
Barriers, beliefs, and biomedical prevention
BACKGROUND: Peripregnant women who use drugs and are involved in the criminal legal system (CLS) face elevated risks of human immunodeficiency virus (HIV) acquisition due to overlapping vulnerabilities, including sexual violence, structural instability, and limited access to preventive healthcare. The unique needs of this population are routinely overlooked in both clinical practice and research. This qualitative study explores peripregnant women…
Promises and pitfalls of safer smoking supply distribution in the United States
With rising prevalence of smoking unregulated drugs across the United States, there is a need for more community-based distribution of safer smoking supplies (e.g., glass pipes) to reduce health harms for people who smoke drugs. While smoking supplies are increasingly offered through harm reduction organizations (HROs), which have predominantly focused on addressing injection-related harms, little is known about HROs’ experiences implementing thi…
Long-Acting Injectable Prep for People Who Inject Drugs at a Syringe Services Program
Although people who inject drugs (PWID) are at high risk of acquiring HIV, knowledge and uptake of pre-exposure prophylaxis (PrEP) for HIV prevention among this population remain low due to numerous psychosocial and structural barriers. Multiple implementation strategies have been proposed to address this gap, notably providing long-acting injectable (LAI) formulations of PrEP and offering PrEP at syringe services programs (SSPs). This qualitativ…
The Simplest Way to Go”
Long-acting injectable PrEP was approved for use in the US in 2021 but roll out has been slow, with few studies exploring uptake among cisgender women who inject drugs (WWID). We purposively recruited 25 WWID within 30-days of receiving a PrEP prescription from a low-barrier clinic co-located with a syringe services program to complete semi-structured interviews about PrEP product choice. We used an intersectional lens to compare decision-making …
Blending de-implementation and implementation to promote adoption of universal PrEP guidelines
In 2021, the Centers for Disease Control and Prevention (CDC) proposed updated clinical practice guidelines for Pre-Exposure Prophylaxis (PrEP), marking a significant shift from risk-based screening to discussing PrEP with all sexually active adults. To ensure widespread adoption of new guidelines, this commentary posits that intentional de-implementation of the previous CDC guidelines is necessary to facilitate the adoption, implementation, and …
Intravenous Methamphetamine Use, HIV Status and PrEP Uptake Among a U.S. Sample of 29,880 Gender and Sexual Minorities, 2022–2023
HIV, Drug Use, Sexual Risk (14 obras) · Medicine (14 obras) · Family medicine (10 obras) · HIV/AIDS Research and Interventions (9 obras) · Opioid Use Disorder Treatment (7 obras) · Psychiatry (7 obras) · Public health (7 obras) · Environmental health (6 obras) · Harm reduction (6 obras) · Nursing (6 obras)